These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

700 related articles for article (PubMed ID: 7533301)

  • 1. Picornavirus inhibitors.
    Carrasco L
    Pharmacol Ther; 1994; 64(2):215-90. PubMed ID: 7533301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibitors of picornavirus replication.
    De Palma AM; Vliegen I; De Clercq E; Neyts J
    Med Res Rev; 2008 Nov; 28(6):823-84. PubMed ID: 18381747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and development of antipicornaviral agents.
    McKinlay MA
    Scand J Infect Dis Suppl; 1993; 88():109-15. PubMed ID: 8516662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense DNA and RNA agents against picornaviruses.
    Lim T; Yuan J; Zhang HM; Sall A; Liu Z; Su Y; Yang D
    Front Biosci; 2008 May; 13():4707-25. PubMed ID: 18508540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of 3C cysteine proteinases from Picornaviridae.
    Lall MS; Jain RP; Vederas JC
    Curr Top Med Chem; 2004; 4(12):1239-53. PubMed ID: 15320724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent development of 3C and 3CL protease inhibitors for anti-coronavirus and anti-picornavirus drug discovery.
    Ramajayam R; Tan KP; Liang PH
    Biochem Soc Trans; 2011 Oct; 39(5):1371-5. PubMed ID: 21936817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses.
    Kim Y; Lovell S; Tiew KC; Mandadapu SR; Alliston KR; Battaile KP; Groutas WC; Chang KO
    J Virol; 2012 Nov; 86(21):11754-62. PubMed ID: 22915796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of anti-picornavirus therapies.
    Barnard DL
    Curr Pharm Des; 2006; 12(11):1379-90. PubMed ID: 16611122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete genome sequence of a novel picornavirus, canine picornavirus, discovered in dogs.
    Woo PC; Lau SK; Choi GK; Yip CC; Huang Y; Tsoi HW; Yuen KY
    J Virol; 2012 Mar; 86(6):3402-3. PubMed ID: 22354943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pleconaril, a new aniviral drug with activity against picornavirus].
    Reina J; Ballesteros F
    Rev Esp Quimioter; 2000 Sep; 13(3):257-62. PubMed ID: 11086273
    [No Abstract]   [Full Text] [Related]  

  • 11. Protease inhibitors as potential antiviral agents for the treatment of picornaviral infections.
    Wang QM
    Prog Drug Res; 1999; 52():197-219. PubMed ID: 10396129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of picornavirus uncoating as antiviral agents.
    Diana GD; Otto MJ; McKinlay MA
    Pharmacol Ther; 1985; 29(3):287-97. PubMed ID: 3014575
    [No Abstract]   [Full Text] [Related]  

  • 13. Sequence analysis of a duck picornavirus isolate indicates that it together with porcine enterovirus type 8 and simian picornavirus type 2 should be assigned to a new picornavirus genus.
    Tseng CH; Tsai HJ
    Virus Res; 2007 Nov; 129(2):104-14. PubMed ID: 17686542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The possible role of the equestron as an Achilles' heel for chemotherapy of picornavirus infections.
    Cooper PD
    Ann N Y Acad Sci; 1977 Mar; 284():650-61. PubMed ID: 212991
    [No Abstract]   [Full Text] [Related]  

  • 15. Picornaviral 3C protease inhibitors and the dual 3C protease/coronaviral 3C-like protease inhibitors.
    Wang HM; Liang PH
    Expert Opin Ther Pat; 2010 Jan; 20(1):59-71. PubMed ID: 20021285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Picornavirus morphogenesis.
    Jiang P; Liu Y; Ma HC; Paul AV; Wimmer E
    Microbiol Mol Biol Rev; 2014 Sep; 78(3):418-37. PubMed ID: 25184560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of a cell-based protease assay for testing inhibitors of picornavirus 3C proteases.
    van der Linden L; Ulferts R; Nabuurs SB; Kusov Y; Liu H; George S; Lacroix C; Goris N; Lefebvre D; Lanke KH; De Clercq K; Hilgenfeld R; Neyts J; van Kuppeveld FJ
    Antiviral Res; 2014 Mar; 103():17-24. PubMed ID: 24393668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in human picornavirus research: New findings from the AIROPico consortium.
    Wolthers KC; Susi P; Jochmans D; Koskinen J; Landt O; Sanchez N; Palm K; Neyts J; Butcher SJ
    Antiviral Res; 2019 Jan; 161():100-107. PubMed ID: 30472162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Avian picornaviruses: molecular evolution, genome diversity and unusual genome features of a rapidly expanding group of viruses in birds.
    Boros Á; Pankovics P; Reuter G
    Infect Genet Evol; 2014 Dec; 28():151-66. PubMed ID: 25278047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual and common inhibitors of coronavirus and picornavirus main proteases.
    Kuo CJ; Liu HG; Lo YK; Seong CM; Lee KI; Jung YS; Liang PH
    FEBS Lett; 2009 Feb; 583(3):549-55. PubMed ID: 19166843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.